Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilocarpine orally dissolving tablets for xerostomia
ACTRN12617001067369Phase 2Terminated
- Sponsor
- The University of Queensland
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in xerostomia comparing Pilocarpine ODT period with Placebo ODT period (2 arms). Primary endpoint: Mean change from baseline in Subjective Rating of Symptoms questionnaire. Started Jan 2018; status: terminated.
02
Drugs
pilocarpine
03
Conditions
xerostomia
Beyond the preview
Go deeper on ACTRN12617001067369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617001067369.